The Influence of Attitudes, Decisional Conflict, and Health Beliefs on Prostate Cancer Screening Intentions and Actions

2002 ◽  
Author(s):  
Robert M. Hamm ◽  
David E. Bard
2016 ◽  
Vol 24 (2) ◽  
pp. 296-313
Author(s):  
Mohammad H. Abuadas ◽  
Wasileh Petro-Nustas ◽  
Zainab F. Albikawi ◽  
Manar Nabolsi

Background: Examining men’s health beliefs regarding prostate cancer screening is a vital issue and requires a reliable and valid scale. Purpose: Modify Champion’s Revised Health Belief Model Scale to measure Jordanian men’s beliefs about PCS, translate to Arabic, culturally adapt, and test its psychometric prosperities. Method: This was a methodological study in which 432 healthy men were selected by convenient sampling. Analysis included estimation of content validity indices, internal consistency, construct validity, and predictive validity. Results: Exploratory factor analysis yielded seven significant factors which explained variance 68.9% of variance. Confirmatory factor analysis demonstrated that scale fit the data significantly. Cronbach’s alpha coefficient ranged from .83 to .92. Conclusion: Scale was found to be a valid and reliable for use with Jordanian men.


2017 ◽  
Vol 4 (5) ◽  
pp. 1021-1021 ◽  
Author(s):  
Motolani E. Ogunsanya ◽  
Carolyn M. Brown ◽  
Folakemi T. Odedina ◽  
Jamie C. Barner ◽  
Taiwo Adedipe

2016 ◽  
Vol 4 (5) ◽  
pp. 1009-1020 ◽  
Author(s):  
Motolani E. Ogunsanya ◽  
Carolyn M. Brown ◽  
Folakemi T. Odedina ◽  
Jamie C. Barner ◽  
Taiwo Adedipe

10.2196/15502 ◽  
2020 ◽  
Vol 8 (5) ◽  
pp. e15502 ◽  
Author(s):  
Jennifer Dacey Allen ◽  
Amanda Reich ◽  
Adolfo G Cuevas ◽  
Keren Ladin

Background African American men are at a higher risk of developing and dying from prostate cancer compared to white men. The serum prostate-specific antigen (PSA) screening test has a high risk of false-positive results and overdiagnosis; therefore, it is not routinely recommended. Rather, men are encouraged to make individualized decisions with their medical providers, after being fully informed about its potential benefits, limitations, and risks. Objective This study aimed to describe the development and pilot testing of an interactive Web-based decision aid (DA; Prostate Cancer Screening Preparation [PCSPrep]) for African American men, designed to promote informed decision making for prostate cancer screening. Methods Four focus groups (n=33) were conducted to assess men’s reactions to DAs developed in prior studies and gather information to modify the content and format. The pilot test employed a pre-posttest evaluation design. A convenience sample of 41 men aged 45-70 years with no history of prostate cancer was recruited from community settings. Participants completed online surveys before and after using PCSPrep that assessed prostate cancer screening knowledge, decision self-efficacy, decisional conflict, and preparation for decision making. Results Use of PCSPrep was associated with a significant increase in prostate cancer knowledge (49% vs 62% correct responses; P<.001), and men also experienced less decisional conflict (24 vs 15 on a scale of 0-100; P=.008). No changes in self-efficacy about decision making or screening preferences were observed. Most men (81%) reported that using PCSPrep prepared them to make informed decisions in partnership with their provider. Conclusions PCSPrep was an acceptable DA that improved men’s knowledge, reduced decisional conflict, and promoted the perception of being prepared for shared decision making. Further research is needed to test the DA in a larger randomized trial.


2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 1528-1528
Author(s):  
S. W. Gray ◽  
N. Wong ◽  
B. Kelly ◽  
A. Romantan ◽  
S. Ramirez ◽  
...  

1528 Background: Cancer screening for colon, breast, and prostate cancer remains underutilized. Physician (MD)-patient discussions of screening are common but the impact of these discussions is unknown. Methods: 2489 40–70 year old subjects completed a national survey of cancer prevention information acquisition and decision making (median age 53, 49% male, 77% white, 59% married, 61% some college). Subjects reported whether their MD initiated discussions (MDID) about colonoscopy, mammography, & PSA within the past year. Age eligible subjects were “non-routine screeners” (NRS: never screened or colonoscopy >10 yrs, mammography >2 yrs or PSA>2 yrs prior) or “routine screeners” (RS).The endpoint was intention to screen when next eligible. Results: 46%, 75% and 60% of subjects reported intentions to obtain colonoscopy, mammography and/or PSA. Logistic regression was used to determine the association between MDID and intentions to screen controlling for sociodemographics and recency of screening. For colonoscopy and mammography, MDID was significantly associated with intention to screen for NRS but not RS groups; the opposite was true for PSA. For the NRS group: comparing those saying no versus yes to MDID, intentions were 15% vs. 43% for colonoscopy, 29% to 61% for mammography (RS: 85% vs. 91% and 82% vs. 85%). For PSA, NRS: 46% vs.52% but RS group 65% vs. 85%. All interactions (screening by MDID) were significant, p<.001. Conclusions: Given high intentions to undergo colon and breast cancer screening among patients who have been screened routinely, physician discussion preferentially increases intentions for colon and breast cancer screening among patients who are not routinely undergoing the screening test. Conversely, physician discussion preferentially influences prostate cancer screening intentions among patients who have been screened in the past two years- perhaps because men who have not undergone screening are more resolved in their decision not to screen. These results define subgroups of patients where physician attention may have the greatest impact on screening adherence. No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document